ITGA2 and cancer: In cancer tissues, the expression of ITGA2 was observed to have varying levels: weak expression was present in 25.8% (16/62) of cases, moderate intensity expression was found in 22.6% (14/62) of cases, and high expression was detected in 51.6% (32/62) of cases.